Repositioning of bromocriptine for treatment of acute myeloid leukemia.

about

Drug Repurposing for the Treatment of Acute Myeloid Leukemia.

P2860

Q47094576-47F91DB5-397B-455B-9ED8-68299F281E89

P2860

Repositioning of bromocriptine for treatment of acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q41040260

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Repositioning of bromocriptine for treatment of acute myeloid leukemia.

@en

type

Item

label

Repositioning of bromocriptine for treatment of acute myeloid leukemia.

@en

prefLabel

Repositioning of bromocriptine for treatment of acute myeloid leukemia.

@en

P1476

Repositioning of bromocriptine for treatment of acute myeloid leukemia.

@en

P2093

Amaia Etxabe

http://www.w3.org/2001/XMLSchema#string

Antònia Banús-Mulet

http://www.w3.org/2001/XMLSchema#string

Jordi Esteve

http://www.w3.org/2001/XMLSchema#string

Marina Díaz-Beyá

http://www.w3.org/2001/XMLSchema#string

María Carmen Lara-Castillo

http://www.w3.org/2001/XMLSchema#string

Meritxell Nomdedeu

http://www.w3.org/2001/XMLSchema#string

Miguel Ángel Torrente

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Expression and pharmacological characterization of the human D3 dopamine receptor

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes

Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

Drug repositioning: identifying and developing new uses for existing drugs

XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells.

Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells.

Cytogenetics in acute leukemia.

P2888

s12967-016-1007-5

P304

261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-016-1007-5

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ruth M Risueño

Josep Maria Cornet-Masana

P577

2016-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1023430346

http://www.w3.org/2001/XMLSchema#string

P698

27604463

http://www.w3.org/2001/XMLSchema#string

P932

5015257

http://www.w3.org/2001/XMLSchema#string

Repositioning of bromocriptine for treatment of acute myeloid leukemia.

about

P2860

P2860

Repositioning of bromocriptine for treatment of acute myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P932